The CSA is tasked to: (1) formulate and update guidelines for the ethical conduct of human health research; (2) develop guidelines for the establishment and management of RECs and standardization of research ethics review; and (3) monitor and evaluate the performance of RECs in accordance with PHREB approved procedures outlined in a prior agreement including requiring an annual report.

The PHREB CSA awards any of the following levels of accreditation to an REC after an evaluation process:

Level 1 Accreditation

Level 1 accreditation is given to new REC applicants.  It allows new RECs to acquire experience in the review of research studies and gives opportunity to comply with the recommendations of the CSA. A level 1 accredited REC reviews all types of research projects except clinical trials required for FDA registration of new drugs.

The REC shall submit required documents according to Section VI.1.4 of the PHREB Policies and Requirements for Accreditation of Research Ethics Committees (RECs) within the first six (6) months.

Within the year, the PHREB-CSA/REMB-CSA may recommend either submission of application for Level 2 or extension of Level 1 provisional accreditation and require further training and submission of additional evidence of compliance.

Level 2 Accreditation

Level 2 accredited REC reviews all types of research except clinical trials required for FDA registration of new drugs.

RECs who have demonstrated satisfactory performance as a Level 1 REC (i.e., functional structure and composition, adequate SOPs, adequate administrative support, effective management of files and archiving) may apply for Level 2. RECs who have not been accredited but have been operating for more than six (6) months can apply for Level 2 accreditation provided they can submit all the necessary requirements.

Level 2 accreditation may be granted for one (1) or three (3) years depending on the degree of satisfactory compliance with the CSA recommendations with regard to quality and documentation of review.

Level 3 Accreditation

Level 3 Accredited REC reviews all types of researches including studies required in applications for marketing authorization of food, drugs and devices by a regulatory agency (i.e., FDA).

Level 3 accreditation may be granted for one (1) or three (3) years depending on the degree of satisfactory compliance with ICH-GCP standards and CSA recommendations with regard to quality and documentation of review.

 

The Committee members:

Chair

 

 Dr. Sonia Bongala

 

Vice Chair

 

Dr. Rhodora Estacio

 

Members

 

Dr. Marita Reyes

 Dr. Cecilia Tomas

 Dr. Ma. Salome Vios

Dr. Milagros Viacrucis

Dr. Evelyn Lacson

 Dr. Prospero Ma. Tuaño

Dr. Froilan Obillo

Dr. Marissa Orillaza

Dr. Concesa Padilla

Prof. Edlyn Jimenez

Prof. Michael Jorge Peralta

 

                                

The CIDTA (1) promotes the establishment of functional and effective ethics review committees; (2) develops training curriculum for research ethics; (3) conducts research ethics training; and (4) trains research ethics trainers.

 

The Committee members:

Chair

 

Dr. Ricardo Manalastas, Jr.

 

Members

 

Dr. Rosario Angeles Alora

Dr. Marita Reyes

Dr. Cecilia Tomas

Dr. Liane Alampay

Dr. Josephine Lumitao

Dr. Angelica Francisco

Dr. Roland Panaligan

Prof. Peter Sy

 

                                

The CPFCE ensures that the policies of PHREB in promoting and safeguarding the rights and welfare of human participants in research are being addressed.

 

The Committee members:

Chair

 

Ms. Carmen Auste

 

Members

 

Dr. Clemen Aquino

Ms. Kara Magsanoc-Alikpala

Ms. Cecilia Sison

Mr. Josef de Guzman

Mr. Paul Perez

Dr. Robert Louie So

 

                                

Please publish modules in offcanvas position.